Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.
Conrad O, Burgy M, Foppolo S, Jehl A, Thiéry A, Guihard S, Vauchelles R, Jung AC, Mourtada J, Macabre C, Ledrappier S, Chenard MP, Onea MA, Danic A, Dourlhes T, Thibault C, Schultz P, Dontenwill M, Martin S. Conrad O, et al. Among authors: guihard s. Int J Mol Sci. 2023 Jul 6;24(13):11178. doi: 10.3390/ijms241311178. Int J Mol Sci. 2023. PMID: 37446353 Free PMC article.
[Stereotactic radiotherapy of intracranial benign tumors].
Noël G, Bauer N, Clavier JB, Guihard S, Lim O, Jastaniah Z. Noël G, et al. Among authors: guihard s. Cancer Radiother. 2012 Sep;16(5-6):410-7. doi: 10.1016/j.canrad.2012.07.179. Epub 2012 Aug 24. Cancer Radiother. 2012. PMID: 22921979 Review. French.
[Dental state in patients with head and neck cancers].
Rouers M, Truntzer P, Dubourg S, Guihard S, Antoni D, Noël G. Rouers M, et al. Among authors: guihard s. Cancer Radiother. 2015 May;19(3):205-10; quiz 230, 234. doi: 10.1016/j.canrad.2015.01.004. Epub 2015 Apr 27. Cancer Radiother. 2015. PMID: 25937188 Review. French.
MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.
Bonnin N, Armandy E, Carras J, Ferrandon S, Battiston-Montagne P, Aubry M, Guihard S, Meyronet D, Foy JP, Saintigny P, Ledrappier S, Jung A, Rimokh R, Rodriguez-Lafrasse C, Poncet D. Bonnin N, et al. Among authors: guihard s. Oncotarget. 2016 Jul 12;7(28):44023-44038. doi: 10.18632/oncotarget.9829. Oncotarget. 2016. PMID: 27281619 Free PMC article.
Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer.
Borel C, Regnier-Gavier O, Carinato H, Guihard S, Antoni D, Demarchi M, Sirlin F, Exinger D, Petit-Jean E, Thiery A, Bronner G, Schultz P, Flesch H, Frasie V, Prébay D, Petit T, Jung AC, Burgy M, Coliat P. Borel C, et al. Among authors: guihard s. Oncotarget. 2018 Dec 25;9(101):37581-37588. doi: 10.18632/oncotarget.26506. eCollection 2018 Dec 25. Oncotarget. 2018. PMID: 30680071 Free PMC article.
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
Carinato H, Burgy M, Ferry R, Fischbach C, Kalish M, Guihard S, Brahimi Y, Flesch H, Bronner G, Schultz P, Frasie V, Thiéry A, Demarchi M, Petit T, Jung AC, Wagner P, Coliat P, Borel C. Carinato H, et al. Among authors: guihard s. Front Oncol. 2021 Oct 27;11:714551. doi: 10.3389/fonc.2021.714551. eCollection 2021. Front Oncol. 2021. PMID: 34778031 Free PMC article.
48 results